Consultative services and external peer review for scientific assessments, literature reviews, and models for the division of risk and decision analysis

Ended Awarded Last action

Contract number
75F40123F80342
Awardee
Awarding agency
Obligated
$1,096,823

Award facts

Opportunity
  • 75F40123Q00361 Solicitation number
Contract value 100% obligated
$1,096,822.79 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20005, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$761,888
Other Administrative Action P00002 $0
Change Order P00001 · The purpose of this modification is to provide services to FDA by organizing and conducting an expert external peer review of the research conducted in… $29,448
Original award $1,829,262

About this award

The Food and Drug Administration issued a delivery order to Versar, Inc., on September 1, 2023, under the GSA Multiple Award Schedule (MAS) for consultative services and external peer review of scientific assessments, literature reviews, and models supporting the Division of Risk and Decision Analysis, with a ceiling value of $1,096,822.79.

Place of performance is Washington, DC. The order's ultimate completion date is March 24, 2025. Work encompasses organizing and conducting expert external peer review of research in support of Front of Package labeling research.

Service Contract Inventory data show $383 thousand invoiced across FY2024 and FY2025, with 1.0 to 1.1 FTEs reported. FY2024 invoiced $101 thousand across 2,276 contractor hours at a derived government-paid rate of $44.39 per hour. FY2025 reported 1.0 FTEs with $382 thousand invoiced. Versar self-performed all reported hours with no subcontractors on this order.

Quick answers

Who was awarded contract 75F40123F80342?

75F40123F80342 was awarded to Versar, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 1, 2023.

How much is contract 75F40123F80342 worth?

The government has obligated $1,096,823 on 75F40123F80342.

Is contract 75F40123F80342 an order under another contract?

Yes. 75F40123F80342 is a delivery order under 47QRAA22D0055, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40123F80342 competed?

The extent of competition for 75F40123F80342 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award